منابع مشابه
Adult ADHD and amphetamines: a new paradigm
ISSN 1758-2008 10.2217/NPY.11.63 © 2011 Future Medicine Ltd Neuropsychiatry (2011) 1(6), 591–598 Summary This review examines the diagnostic validity of adult ADHD on the basis of phenomenology, genetics, course of illness and treatment response in the context of a diagnostic hierarchy. In addition, it examines ADHD treatment options, particularly amphetamine use, associated risks and the clini...
متن کاملParticulate Contamination in Single-Dose Parenteral Antibiotics in Iran
In order to ensure the safety of parenterals, international pharmacopoeias and national standards have set up stringent guidelines and standards. Particulate con- tamination is a potential health risk caused by intravenous injection of particles large enough to potentially clog the small arteries. Particles could be produced through manufacturing and packaging or even dispensing of the ph...
متن کاملSingle dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD.
The effect of CYP2D6 genotype on the dose-exposure relationship for atomoxetine has not been well characterized in children. Children 6-17 years of age diagnosed with attention-deficit hyperactivity disorder (ADHD) were stratified by CYP2D6 genotype into groups with 0 (poor metabolizers [PMs], n = 4), 0.5 (intermediate metabolizers [IMs], n = 3), one (extensive metabolizer [EM]1, n = 8) or two ...
متن کاملAttention benefits after a single dose of metadoxine extended release in adults with predominantly inattentive ADHD.
OBJECTIVE To assess the first-dose effectiveness and tolerability of metadoxine extended release (MDX) in adults with predominantly inattentive attention-deficit/hyperactivity disorder (ADHD-PI). METHODS In this double-blind, placebo-controlled, crossover study, adults with ADHD-PI were randomized 1:1:1 to receive a single dose of MDX 1400 mg, MDX 700 mg, and placebo (ClinicalTrials.gov ident...
متن کاملThe pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?
Attention-deficit hyperactivity disorder (ADHD) treatment options include pharmacological and nonpharmacological approaches. In North America, psychostimulants (amphetamine and methylphenidate) are considered first-line pharmacological treatments for patients (children, adolescents and adults) with ADHD. However, in the UK, National Institute for Health and Clinical Excellence (NICE) guidelines...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Neurology Briefs
سال: 2001
ISSN: 2166-6482,1043-3155
DOI: 10.15844/pedneurbriefs-15-11-1